Additionally, p16 positive cases showed significantly higher SEC62 expression levels compared to p16 negative samples in our study cohort, which might have counteracted the well-known beneficial effects of HPV-associated tumor cell biology in terms of treatment response. The gene discussed is SEC62; the disease is neoplasm.